Depressive and Anxiety Disorders in Patients With Chronic Liver Diseases
Prevalence of Depressive Disorders and Anxiety Disorders Among Sample of Patients With Chronic Liver Disease Attending Assiut University Hospitals.
1 other identifier
observational
118
1 country
1
Brief Summary
The aim of this observational study is to learn about the prevalence of depressive and anxiety disorders among patients with chronic liver diseases
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2023
CompletedFirst Posted
Study publicly available on registry
November 2, 2023
CompletedStudy Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedNovember 27, 2023
November 1, 2023
10 months
October 26, 2023
November 23, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants that experienced depressive or anxiety disorders
Each participant will be asked to fill items of questionnaires like The Beck Depression inventor, The Hamilton Rating Scale for Anexity and Rand SF-36 Questionnaire
Baseline
Study Arms (2)
Healthy group
Participants not known to have neither chronic liver diseases nor Psychiatric disorders
Diseased group
Participants known to have chronic liver diseases
Interventions
The scale consists of 14 items, each defined by a series of symptoms, and measures both psychic anxiety (mental agitation and psychological distress) and somatic anxiety (physical complaints related to anxiety).
one of the most widely used instruments for measuring the severity of depression
The SF-36 measures eight scales: physical functioning (PF), role physical (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH). Component analyses showed that there are two distinct concepts measured by the SF-36: a physical dimension, represented by the Physical Component Summary (PCS), and a mental dimension, represented by the Mental Component Summary (MCS). All scales do contribute in different proportions to the scoring of both PCS and MCS measures
Eligibility Criteria
Patients with chronic liver diseases
You may qualify if:
- patients admitted or attending at Rajhi university hospital with chronic liver disease including: viral (hepatitis B and C), autoimmune (primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis), non-alcoholic steatohepatitis, Morbus Wilson and cryptogenic CLD.
- age group above 18 years old.
You may not qualify if:
- patients with chronic liver disease with other psychiatric disorders other than depression and anxiety.
- patients with acute complication of chronic liver disease.
- patients with chronic liver disease who underwent liver transplation.
- patients with chronic liver disease under antiviral therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Salma Ashraf Mohamed Badr
Asyut, 71745, Egypt
Related Publications (3)
Vahia VN. Diagnostic and statistical manual of mental disorders 5: A quick glance. Indian J Psychiatry. 2013 Jul;55(3):220-3. doi: 10.4103/0019-5545.117131. No abstract available.
PMID: 24082241BACKGROUNDKessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593-602. doi: 10.1001/archpsyc.62.6.593.
PMID: 15939837BACKGROUNDHuang X, Liu X, Yu Y. Depression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms? Front Mol Neurosci. 2017 May 8;10:134. doi: 10.3389/fnmol.2017.00134. eCollection 2017.
PMID: 28533742BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 26, 2023
First Posted
November 2, 2023
Study Start
December 1, 2023
Primary Completion
September 30, 2024
Study Completion
October 1, 2024
Last Updated
November 27, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will share